SILPA-ARCHA, S. Et Al. 2016. Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.. Acta ophthalmologica , vol.94 .

SILPA-ARCHA, S., Oray, M., PREBLE, J., & FOSTER, C., (2016). Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.. Acta ophthalmologica , vol.94.

SILPA-ARCHA, S Et Al. "Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.," Acta ophthalmologica , vol.94, 2016

SILPA-ARCHA, S Et Al. "Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.." Acta ophthalmologica , vol.94, 2016

SILPA-ARCHA, S. Et Al. (2016) . "Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.." Acta ophthalmologica , vol.94.

@article{article, author={S SILPA-ARCHA Et Al. }, title={Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.}, journal={Acta ophthalmologica}, year=2016}